Susanna Urdmark

Handelsbanken Fonder AB (HBF) is the wholly-owned fund management subsidiary of Handelsbankens Fondbolagsförvaltning AB, ultimately held by Svenska Handelsbanken AB (STO: SHB-A, ADR: SVNLY) in Swede. The firm is headquartered in Stockholm with offices in Luxembourg, Oslo and Helsinki. Founded in 1959, HBF provides financial advisory and investment management services to private individuals as well as corporate and institutional clients including pension funds. They also manage a range of mutual funds as well as exchange-traded funds. The firm is a responsible investor and signatory to the UN Principles for Responsible Investment (UN PRI).

Svenska Handelsbanken AB (Broker) (Handelsbanken-Broker) is the broker/dealer division of Svenska Handelsbanken AB (STO: SHB-A; OTCMKTS: SVNLY) in Sweden. Headquartered in Stockholm, Handelsbanken-Broker was founded in 1871 and provides trading services to large corporates. The firm trades in equities, money market instruments, currencies, commodities and derivatives.

Bluefish Pharmaceuticals AB manufactures generic pharmaceutical products. Its therapeutic areas include analgesic, antibiotics, antifungal, antiviral, cardiovascular, endocrinology, diabetes, gastrointestinal, genito-urinary, inflammatory, oncology, and respiratory. The company was founded by Karl Alexius Tiger Karlsson in 2005 and is headquartered in Stockholm, Sweden.

Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities.

Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala.